The Impact of Polymerase Chain Reaction Urine Testing on Clinical Decision-Making in the Management of Complex Urinary Tract Infections.
Document Type
Article
Publication Date
6-16-2024
Publication Title
International journal of molecular sciences
Abstract
While urinary polymerase chain reaction (PCR) testing is effective in organism identification in patients with complex urinary tract infections (cUTI), limited data exists on the clinical usefulness of this test. We serially surveyed physicians treating symptomatic patients with cUTI both at presentation and after PCR, and urine culture (UC) results were available to ascertain how the test results modified the therapy. A total of 96 unique surveys completed by 21 providers were included in the data analysis. The mean age for female and male patients was 69.4 ± 15.5 and 71.6 ± 12.7 years, respectively. The test positivity and line-item concordance for UC and PCR were consistent with prior reports. The PCR results modified or confirmed treatment in 59/96 (61.5%) and 25/96 (26.0%) of the cases, respectively, with 12/29 (41.4%) and 47/67 (70.1%) having negative and positive PCR results, respectively, resulting in treatment change (difference 28.7%,
Volume
25
Issue
12
First Page
6616
Recommended Citation
Elia J, Hafron J, Holton M, Ervin C, Hollander MB, Kapoor DA. The impact of polymerase chain reaction urine testing on clinical decision-making in the management of complex urinary tract infections. Int J Mol Sci. 2024 Jun 16;25(12):6616. doi: 10.3390/ijms25126616. PMID: 38928323
DOI
10.3390/ijms25126616
ISSN
1422-0067
PubMed ID
38928323